Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products

Analytical Biochemistry

Volumn 388, Issue 2, 2009, Pages 317-321

  Bairstow, Shawn ^a   McKee, Jeff ^a   Nordhaus, Mark ^a   Johnson, Richard ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Heparin; Heparin EIA; Hypotension; Oversulfated chondroitin sulfate

Indexed keywords

CONTAMINATION; MAMMALS; SULFUR COMPOUNDS;

CHONDROITIN SULFATES; CONTAMINATION LEVELS; CRITICALLY-ILL PATIENTS; ENZYME IMMUNOASSAY; HEPARIN; HEPARIN EIA; HYPOTENSION; LIMIT OF DETECTION;

POLYSACCHARIDES;

ANTICOAGULANT AGENT; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARIN; OVERSULFATED CHONDROITIN SULFATE; UNCLASSIFIED DRUG;

ARTICLE; CONTAMINATION; DRUG DETERMINATION; DRUG EFFECT; DRUG IDENTIFICATION; ENZYME IMMUNOASSAY; HYPOTENSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SWINE;

SUIDAE;

EID: 64549101987     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.03.009     Document Type: Article

References (15)

1. Guerrini M., Beccati D., Shriver Z., Naggi A., Viswanathan K., Bisio A., Capila I., Lansing J.C., Guglieri S., Fraser B., Al-Hakim A., Gunay N.S., Zhang Z., Robinson L., Buhse L., Nasr M., Woodcock J., Langer R., Venkataraman G., Linhardt R.J., Casu B., Torri G., and Sasisekharan R. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat. Biotechnol. 26 (2008) 669-675
2. Wielgos T., Havel K., Ivanova N., and Weinberger R. Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers. J. Pharm. Biomed. Anal. 49 (2009) 319-326
3. 1 H NMR spectroscopy. J. Pharm. Biomed. Anal. 49 (2009) 1060-1064
4. Trehy M.L., Reepmeyer J.C., Kolinski R.E., Westenberger B.J., and Buhse L.F. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities. J. Pharm. Biomed. Anal. 49 (2009) 670-673
5. Sitkowski J., Bednarek E., Bocian W., and Kozerski L. Assessment of oversulfated chondroitin sulfate in low molecular weight and unfractioned heparins diffusion ordered nuclear magnetic resonance spectroscopy method. J. Med. Chem. 51 (2008) 7663-7665
6. Hu P., Fang L., and Chess E.K. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application. Anal. Chem. 81 (2009) 2332-2343
7. 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin. J. Pharm. Biomed. Anal. 49 (2009) 816-819
8. Clark M., Hoppensteadt D., Walenga J., Myers L., Cunanan J., Jeske W., Adiguzel C., Iqbal O., and Fareed J. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins: Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate. Intl. Angiol. 27 (2008) 370-376
9. N. Volpi, F. Maccari, R. J. Linhardt, Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations, Anal. Biochem. 388 (2009) 140-145.
10. McEwen I., Mulloy B., Hellwig E., Kozerski L., Beyer T., Holzgrabe U., Wanko R., and Spieser J.M. Determination of oversulphated chondroitin sulphate and dermatan sulphate in unfractionated heparin by 1H-NMR: Collaborative study for quantification and analytical determination of LoD. Pharmeuropa. Bio. 2008 (2008) 31-39
11. Maruyama T., Toida T., Imanari T., Yu G., and Linhardt R.J. Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation. Carbohydr. Res. 306 (1998) 35-43
12. Kishimoto T.K., Viswanathan K., Ganguly T., Elankumaran S., Smith S., Pelzer K., Lansing J.C., Sriranganathan N., Zhao G., Galcheva-Gargova Z., Al-Hakim A., Bailey G.S., Fraser B., Roy S., Rogers-Cotrone T., Buhse L., Whary M., Fox J., Nasr M., Dal Pan G.J., Shriver Z., Langer R.S., Venkataraman G., Austen K.F., Woodcock J., and Sasisekharan R. Contaminated heparin associated with adverse clinical events and activation of the contact system. N. Engl. J. Med. 358 (2008) 2457-2467
13. Cai S., Dufner-Beattie J.L., and Prestwich G.D. A selective protein sensor for heparin detection. Anal. Biochem. 326 (2004) 33-41
14. Leiden J.M. Canaries, coal mines, and the drug supply. Nat. Biotechnol. 26 (2008) 624-626
15. Laurencin C.T., and Nair L. The FDA and safety: beyond the heparin crisis. Nat. Biotechnol. 26 (2008) 621-623